Search Press releases Keywords From To 9 Mar 2023 Cancer Research UK Signs Multi-Project Collaboration With UCB To Advance Oncology Antibody Candidates Read More 9 Mar 2023 UCB’s Board of Directors appoints Jonathan Peacock as new Chair Read More 3 Mar 2023 Acquisition of own shares Read More 24 Feb 2023 Share Repurchase Program 2023 to cover UCB's Long Term Incentive Plans for employees Read More 22 Feb 2023 UCB managed 2022 headwinds and is ready for 2023 launches Read More 8 Feb 2023 FINTEPLA[®]▼ (fenfluramine) oral solution approved in the EU for adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) Read More Pagination First page Previous page Previous … Page 8 Page 9 Page 10 Page 11 Current page 12 Page 13 Page 14 Page 15 Page 16 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
